Alexander A. Santini

2017

In 2017, Alexander A. Santini earned a total compensation of $1.1M as Executive Vice President and Chief Commercial Officer at Lexicon Pharmaceuticals, a 53% increase compared to previous year.

Compensation breakdown

Bonus$93,313
Option Awards$425,329
Salary$393,830
Stock Awards$149,743
Other$11,611
Total$1,073,826

Santini received $425.3K in option awards, accounting for 40% of the total pay in 2017.

Santini also received $93.3K in bonus, $393.8K in salary, $149.7K in stock awards and $11.6K in other compensation.

Rankings

In 2017, Alexander A. Santini's compensation ranked 8,648th out of 14,666 executives tracked by ExecPay. In other words, Santini earned more than 41.0% of executives.

ClassificationRankingPercentile
All
8,648
out of 14,666
41st
Division
Manufacturing
3,288
out of 5,772
43rd
Major group
Chemicals And Allied Products
1,108
out of 2,075
47th
Industry group
Drugs
880
out of 1,731
49th
Industry
Pharmaceutical Preparations
687
out of 1,333
49th
Source: SEC filing on March 16, 2018.

Santini's colleagues

We found four more compensation records of executives who worked with Alexander A. Santini at Lexicon Pharmaceuticals in 2017.

2017

Lonnel Coats

Lexicon Pharmaceuticals

Chief Executive Officer

2017

Praveen Tyle

Lexicon Pharmaceuticals

Executive Vice President, Research and Development

2017

Jeffrey Wade

Lexicon Pharmaceuticals

Chief Financial Officer

2017

Pablo Lapuerta

Lexicon Pharmaceuticals

Chief Medical Officer

News

You may also like